Impact of a genomic classifier of metastatic risk on treatment recommendations post-radical prostatectomy: Report from the DECIDE study group.

Ketan K. Badani,Darby J. S. Thompson,Christine Buerki,Elai Davicioni,Jill Garrison,Mercedeh Ghadessi,Anirban P. Mitra,Penelope J. Wood,John Hornberger

Impact of a genomic classifier of metastatic risk on treatment recommendations post-radical prostatectomy: Report from the DECIDE study group.

2017

Ketan K. Badani
Darby J. S. Thompson
Christine Buerki
Elai Davicioni
Jill Garrison
Mercedeh Ghadessi
Anirban P. Mitra
Penelope J. Wood
John Hornberger

e16044 Background: Only a minority of prostate cancer patients with adverse pathology and biochemical recurrence (BCR) post radical prostatectomy (RP) experience metastasis and die from prostate ca...

Keywords:

breakpoint cluster region
Internal medicine
Oncology
Metastasis
Prostate cancer
Prostatectomy
Prostate
Pathology
Biochemical recurrence
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations